Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014
3 Pogledi
administrator
07/30/23
Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.
Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com
Prikaži više
Komentari na Facebooku
Nema komentara